Growth Metrics

Gilead Sciences (GILD) Other Non-Current Assets (2016 - 2026)

Gilead Sciences filings provide 17 years of Other Non-Current Assets readings, the most recent being $4.8 billion for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 28.55% to $4.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 billion, a 28.55% increase, with the full-year FY2025 number at $4.8 billion, up 28.55% from a year prior.
  • Other Non-Current Assets hit $4.8 billion in Q4 2025 for Gilead Sciences, down from $4.9 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $5.6 billion in Q2 2021 to a low of $3.8 billion in Q4 2024.
  • Median Other Non-Current Assets over the past 5 years was $4.9 billion (2022), compared with a mean of $4.8 billion.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 30.81% in 2024 and later decreased 25.39% in 2025.
  • Gilead Sciences' Other Non-Current Assets stood at $5.0 billion in 2021, then dropped by 3.28% to $4.8 billion in 2022, then fell by 0.17% to $4.8 billion in 2023, then fell by 21.35% to $3.8 billion in 2024, then increased by 28.55% to $4.8 billion in 2025.
  • The last three reported values for Other Non-Current Assets were $4.8 billion (Q4 2025), $4.9 billion (Q3 2025), and $4.0 billion (Q2 2025) per Business Quant data.